Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Acetylcholine Release Inhibitor [EPC]
Sus Scrofa Prostate is a biological extract derived from porcine prostate tissue, classified as an Acetylcholine Release Inhibitor and Androgen. It is utilized in integrative medicine for hormonal and neuromuscular modulation under strict clinical supervision.
Name
Sus Scrofa Prostate
Raw Name
SUS SCROFA PROSTATE
Category
Acetylcholine Release Inhibitor [EPC]
Drug Count
8
Variant Count
9
Last Verified
February 17, 2026
About Sus Scrofa Prostate
Sus Scrofa Prostate is a biological extract derived from porcine prostate tissue, classified as an Acetylcholine Release Inhibitor and Androgen. It is utilized in integrative medicine for hormonal and neuromuscular modulation under strict clinical supervision.
Detailed information about Sus Scrofa Prostate
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Prostate.
Sus Scrofa Prostate is a complex biological medicinal product derived from the prostate gland of the domestic pig (Sus scrofa). In the landscape of modern pharmacology, this agent is uniquely classified under several Established Pharmacologic Classes (EPC), most notably as an Acetylcholine Release Inhibitor [EPC], a Neuromuscular Blocker [EPC], and an Androgen [EPC]. It is also recognized for containing bioactive fractions that function as a Nitrogen Binding Agent [EPC], a Standardized Chemical Allergen [EPC], and endogenous components such as Vitamin C [EPC], Lymphocyte Growth Factor [EPC], and Interferon gamma [EPC]. This multi-faceted profile suggests a substance that does not act on a single receptor but rather modulates a cascade of physiological pathways ranging from hormonal regulation to immune response and neurotransmitter signaling.
Historically, porcine-derived organ extracts have been utilized in a field known as organotherapy or glandular therapy. The rationale behind its use is based on the biological homology between porcine and human tissues. Porcine prostate tissue contains a variety of peptides, signaling molecules, and steroid precursors that are structurally similar to those found in humans. According to the FDA’s regulatory framework for biological products, Sus Scrofa Prostate is often encountered in homeopathic preparations or as a constituent in specific biological therapeutic regimens. While not a first-line therapy for acute conditions, your healthcare provider may consider it in the context of integrative protocols for endocrine support or neuromuscular modulation. It is essential to understand that Sus Scrofa Prostate belongs to a class of drugs that requires careful titration and monitoring due to its potent biological activity.
The mechanism of action (MoA) for Sus Scrofa Prostate is characterized by its poly-pharmacological effects. At the molecular level, it functions primarily as an Acetylcholine Release Inhibitor [MoA]. Acetylcholine is the primary neurotransmitter responsible for muscle contraction and parasympathetic signaling; by inhibiting its release at the presynaptic terminal, Sus Scrofa Prostate can exert a dampening effect on overactive neuromuscular pathways. This is why it is categorized as a neuromuscular blocker, though its potency and site-specificity differ significantly from synthetic agents like vecuronium.
Simultaneously, the agent acts as an Androgen Receptor Agonist [MoA]. The prostate gland is a highly androgen-dependent organ, and its extract contains steroid-binding proteins and precursors that can interact with human androgen receptors (AR). This can influence the transcription of genes involved in male reproductive health and protein synthesis. Furthermore, its role as an Ammonium Ion Binding Activity [MoA] agent suggests a metabolic function in nitrogen clearance, potentially assisting in the detoxification of nitrogenous waste products in the blood. The presence of Interferon gamma and Lymphocyte Growth Factors within the extract further indicates a role in modulating the cellular immune response, specifically by activating macrophages and enhancing the cytotoxicity of T-lymphocytes.
Understanding the pharmacokinetics (the movement of the drug through the body) of a biological extract is complex due to the presence of multiple active constituents.
Sus Scrofa Prostate is utilized in several clinical contexts, though many uses are considered integrative or complementary. Your healthcare provider might utilize this agent for:
Sus Scrofa Prostate is available in several formulations to accommodate different therapeutic needs:
> Important: Only your healthcare provider can determine if Sus Scrofa Prostate is right for your specific condition. The complexity of its biological makeup requires professional diagnostic oversight.
The dosage of Sus Scrofa Prostate must be highly individualized, as it is a biological extract rather than a single synthetic molecule. Standard clinical doses for adult males often range from 200 mg to 500 mg daily when used as a dietary or glandular supplement. In homeopathic medicine, the dosage is determined by the potency (e.g., 5-10 drops of a 6X dilution three times daily). For its use as an Acetylcholine Release Inhibitor, healthcare providers may start with a lower dose to assess the patient's neuromuscular sensitivity before titrating upward.
Sus Scrofa Prostate is generally not approved for pediatric use. Because it contains active androgenic components and growth factors, there is a significant risk of interfering with normal endocrine development and bone maturation (epiphyseal closure) in children. Unless specifically directed by a specialist in pediatric endocrinology for a rare metabolic condition, this agent should be avoided in patients under the age of 18.
Patients with impaired kidney function (reduced GFR) may experience a buildup of nitrogenous metabolites and peptide fragments. While specific dose-adjustment scales do not exist for this biological extract, a reduction of 25-50% in the starting dose is often recommended for patients with Stage 3 or higher chronic kidney disease (CKD). Monitoring of serum creatinine and BUN is essential.
Since the liver is the primary site for the metabolism of the androgenic components of Sus Scrofa Prostate, patients with hepatic insufficiency (e.g., cirrhosis, hepatitis) are at an increased risk of hormonal toxicity. Healthcare providers should use extreme caution and consider lower doses or longer dosing intervals in these patients.
Geriatric patients often have a natural decline in both renal and hepatic clearance. Furthermore, the elderly are more sensitive to the effects of Acetylcholine Release Inhibitors, which can contribute to cognitive changes or urinary retention. Dosing in the elderly should follow the 'start low, go slow' principle, typically beginning at the lowest end of the adult range.
To ensure maximum efficacy and safety, follow these specific instructions:
If you miss a dose of Sus Scrofa Prostate, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of androgenic side effects and neuromuscular blockade.
An overdose of Sus Scrofa Prostate can lead to acute symptoms of androgen excess or excessive acetylcholine inhibition. Signs may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on maintaining respiratory function and managing hormonal fluctuations.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as biological products can have complex withdrawal or rebound effects.
Because Sus Scrofa Prostate contains active hormonal and neurotransmitter-modulating components, side effects are relatively common. The most frequently reported issues include:
> Warning: Stop taking Sus Scrofa Prostate and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of Sus Scrofa Prostate may lead to more significant physiological changes:
No FDA black box warnings currently exist specifically for Sus Scrofa Prostate. However, it is important to note that the FDA has issued general warnings regarding porcine-derived glandular products concerning their lack of standardization and the potential for contamination if not manufactured in cGMP-compliant facilities. Additionally, products with androgenic activity often carry warnings regarding the risk of virilization in women and children who come into accidental contact with the substance.
Report any unusual symptoms to your healthcare provider. Monitoring of hormone levels and liver function is highly recommended for any patient using this agent for longer than three months.
Sus Scrofa Prostate is a potent biological agent that must be handled with the same caution as a pharmaceutical drug. Because it acts as an Acetylcholine Release Inhibitor and an Androgen, it can affect multiple organ systems simultaneously. Patients must be screened for pre-existing hormone-sensitive conditions and neuromuscular disorders before beginning therapy. It is not a simple nutritional supplement; it is a metabolic and endocrine modulator.
Currently, there are no specific FDA black box warnings for Sus Scrofa Prostate. However, healthcare providers often apply the safety standards used for other androgens and neuromuscular agents to this extract. This includes warnings about the potential for liver toxicity and the risks associated with hormonal manipulation in patients with a history of certain cancers.
Patients taking Sus Scrofa Prostate require regular clinical monitoring to ensure safety:
Due to its potential effects as a Neuromuscular Blocker and its ability to cause fatigue or dizziness, patients should observe how they react to Sus Scrofa Prostate before driving or operating heavy machinery. If you experience muscle weakness or blurred vision, avoid these activities and consult your doctor.
Alcohol should be avoided or strictly limited while taking Sus Scrofa Prostate. Alcohol can increase the risk of liver strain when combined with androgenic substances and may potentiate the sedative or neuromuscular effects of the extract, leading to increased coordination issues.
Do not stop taking Sus Scrofa Prostate abruptly if you have been using it for an extended period. Sudden discontinuation of androgenic substances can lead to a "crash" characterized by severe fatigue, depression, and hormonal imbalance. Your healthcare provider will provide a tapering schedule to allow your body's natural hormone production to resume.
> Important: Discuss all your medical conditions, especially any history of cancer, heart disease, or liver problems, with your healthcare provider before starting Sus Scrofa Prostate.
Certain medications must never be used in conjunction with Sus Scrofa Prostate due to the risk of life-threatening interactions:
Sus Scrofa Prostate can interfere with several diagnostic tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the only way to prevent dangerous drug-drug interactions.
Sus Scrofa Prostate must NEVER be used in the following circumstances:
In these conditions, the use of Sus Scrofa Prostate requires a careful risk-benefit analysis by a specialist:
Patients who have reacted poorly to other glandular extracts (such as bovine orchic extract or porcine thyroid) are likely to have a cross-sensitivity to Sus Scrofa Prostate. Additionally, there is a theoretical cross-sensitivity with certain neuromuscular blocking agents used in anesthesia. If you have ever had a complication during general anesthesia, inform your doctor before starting this medication.
> Important: Your healthcare provider will evaluate your complete medical history, including family history of cancer and cardiovascular health, before prescribing Sus Scrofa Prostate.
Sus Scrofa Prostate is classified as Category X (or the equivalent under modern labeling) for pregnancy. It is strictly contraindicated. The androgenic components can cause "virilization" in a female fetus, which involves the development of male physical characteristics. Furthermore, the presence of Interferon gamma [EPC] can alter the maternal immune environment, potentially leading to pregnancy loss or developmental abnormalities. If pregnancy occurs while taking this drug, it must be discontinued immediately, and the patient must be counseled on the potential risks to the fetus.
It is unknown if the specific peptide and hormonal components of Sus Scrofa Prostate pass into human breast milk. However, many steroid hormones do cross into milk and can cause adverse effects in the nursing infant, such as premature puberty or growth disturbances. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Sus Scrofa Prostate is not approved for use in children. The risks include premature closure of the growth plates in bones (epiphyseal closure), which leads to permanent short stature. It can also cause precocious (early) puberty and inappropriate development of secondary sexual characteristics. Its use as an Acetylcholine Release Inhibitor in children has not been studied and could lead to significant developmental delays in the nervous system.
Elderly patients (over 65) are at a higher risk for several complications:
In patients with kidney disease, the excretion of the Nitrogen Binding Agent metabolites and peptide fragments is impaired. This can lead to an accumulation of nitrogenous waste, potentially causing uremia-like symptoms. Dosing should be based on the patient's Creatinine Clearance (CrCl). For CrCl < 30 mL/min, the use of Sus Scrofa Prostate is generally discouraged.
For patients with mild to moderate hepatic impairment (Child-Pugh Class A or B), frequent monitoring of liver enzymes is required. In patients with severe hepatic impairment (Child-Pugh Class C), the drug is contraindicated because the liver cannot safely metabolize the androgenic steroids, leading to a high risk of systemic toxicity.
> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring than the general population.
Sus Scrofa Prostate exerts its effects through a multi-target biological approach. As an Acetylcholine Release Inhibitor [MoA], it acts on the presynaptic membrane of cholinergic neurons. It is thought to interfere with the calcium-dependent exocytosis of acetylcholine vesicles, thereby reducing the amount of neurotransmitter available in the synaptic cleft. This results in a mild neuromuscular blockade and a reduction in parasympathetic tone.
As an Androgen Receptor Agonist [MoA], the steroid fractions (including testosterone precursors and 5-alpha-reduced metabolites) bind to the cytoplasmic androgen receptor. This complex then translocates to the nucleus, where it binds to androgen response elements (AREs) on the DNA, initiating the transcription of genes responsible for protein synthesis and male secondary sexual characteristics. The Ammonium Ion Binding Activity [MoA] is facilitated by specific porcine proteins that act as molecular sponges for excess nitrogen, aiding in the urea cycle's efficiency.
The dose-response relationship for Sus Scrofa Prostate is non-linear, which is typical for biological extracts. Low doses may primarily affect the immune system (via Interferon gamma), while higher doses are required to achieve significant androgenic or neuromuscular effects. The time to onset for the neuromuscular effects is relatively fast (2-4 hours), whereas the hormonal effects may take several weeks of consistent dosing to become clinically evident. Tolerance to the neuromuscular blocking effects can develop over time, requiring dose adjustments.
| Parameter | Value |
|---|---|
| Bioavailability | 15-25% (Oral, highly variable) |
| Protein Binding | 85-95% (primarily to SHBG and Albumin) |
| Half-life | 4-12 hours (Peptides); 2-3 days (Steroids) |
| Tmax | 1-3 hours (Peptides); 4-6 hours (Lipids) |
| Metabolism | Hepatic (CYP3A4, Glucuronidation) |
| Excretion | Renal (60%), Fecal (35%), Sweat/Other (5%) |
Sus Scrofa Prostate is classified as a Biological Androgen and a Neuromuscular Modulator. It is related to other porcine-derived products such as Thyroid (USP) and Porcine Insulin, though its specific application in prostate and neuromuscular health is distinct. Within the EPC system, it is categorized as an Acetylcholine Release Inhibitor, placing it in a unique niche between hormonal therapy and neurology.
Common questions about Sus Scrofa Prostate
Sus Scrofa Prostate is primarily used in integrative medicine to support male hormonal health and modulate neuromuscular signaling. Because it is classified as an Androgen [EPC], it may be prescribed by healthcare providers to help balance testosterone-related pathways. Its role as an Acetylcholine Release Inhibitor also makes it a candidate for addressing conditions involving overactive muscle signaling. Additionally, it contains growth factors and immune modulators like Interferon gamma, which may support the body's cellular defense mechanisms. Always consult a doctor to see if this specific biological extract is appropriate for your clinical needs.
The most common side effects include gastrointestinal issues such as nausea, bloating, and abdominal discomfort, which often occur as the body adjusts to the porcine proteins. Patients may also experience mild androgenic effects like increased skin oiliness or acne. Fatigue is another frequently reported symptom, likely due to the modulation of acetylcholine levels in the nervous system. While these are usually mild, they should be reported to a healthcare provider if they persist. Most common side effects tend to diminish after the first few weeks of consistent use.
It is strongly advised to avoid or significantly limit alcohol consumption while taking Sus Scrofa Prostate. Alcohol can place additional strain on the liver, which is already working to metabolize the androgenic components of the extract. Furthermore, alcohol has its own effects on the central nervous system and neuromuscular coordination, which can unpredictably interact with the drug's Acetylcholine Release Inhibitor properties. This combination could lead to increased dizziness, sedation, or muscle weakness. Discuss your alcohol intake with your doctor to ensure your safety during treatment.
No, Sus Scrofa Prostate is strictly contraindicated during pregnancy and is typically assigned to Pregnancy Category X. The androgenic components can cause permanent physical abnormalities in a female fetus, a process known as virilization. Additionally, the immune-modulating components like Interferon gamma could potentially interfere with the normal immune tolerance required for a healthy pregnancy. Women of childbearing age should use effective contraception while taking this medication. If you suspect you are pregnant, stop taking the supplement immediately and contact your healthcare provider.
The timeframe for seeing results from Sus Scrofa Prostate depends on the condition being treated. The neuromuscular effects, such as changes in muscle tone or signaling, may be noticed within a few days of starting treatment. However, the hormonal and endocrine benefits, which rely on gene transcription via androgen receptors, typically take 4 to 8 weeks of consistent use to become apparent. Immune-modulating effects may also take several weeks to manifest. Your doctor will likely schedule follow-up appointments at the 2-month mark to evaluate the drug's efficacy.
You should not stop taking Sus Scrofa Prostate suddenly without consulting your healthcare provider, especially if you have been using it for a long period. Because it provides exogenous androgenic support, your body's natural hormone production may have slowed down. Abruptly stopping can cause a hormonal 'crash,' leading to symptoms like extreme fatigue, mood swings, and depression. A medically supervised tapering schedule is usually recommended to allow your endocrine system to regain its natural balance. Always follow the discontinuation plan provided by your medical professional.
If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for a missed one, as this can increase the risk of acute side effects like muscle weakness or hormonal spikes. Consistency is key for biological extracts, so try to take your medication at the same time each day. If you miss multiple doses, contact your doctor for advice on how to restart.
Sus Scrofa Prostate can cause changes in body composition, which some patients may perceive as weight gain. As an androgen, it can promote muscle protein synthesis, which may increase lean body mass. However, it can also cause fluid retention (edema), leading to a quick increase in scale weight, particularly in the legs and ankles. If you notice rapid weight gain (more than 3-5 pounds in a week) or significant swelling, contact your doctor, as this may indicate a strain on your heart or kidneys. It is important to distinguish between muscle gain and fluid retention.
Sus Scrofa Prostate has several significant drug interactions that must be managed by a professional. It should never be taken with cholinesterase inhibitors or other neuromuscular blockers due to the risk of respiratory issues. It can also increase the effects of blood thinners like Warfarin, raising the risk of bleeding. Because it affects insulin sensitivity, diabetics may need to adjust their medication doses. Always provide your healthcare provider with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking to prevent dangerous interactions.
Sus Scrofa Prostate is a biological extract, and the concept of 'generic' versions is different than for synthetic drugs. While there are various brands of porcine prostate glandular extracts available, they are not necessarily bioequivalent because the manufacturing processes (like freeze-drying vs. chemical extraction) vary between companies. These are often sold as dietary supplements or homeopathic remedies rather than FDA-approved generic drugs. It is crucial to use a high-quality, standardized product from a reputable manufacturer to ensure you are receiving the correct amount of active biological components.